LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma

NCT03287947 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Low enrollment

Conditions

Appendix Cancer

Interventions

DRUG: nintedanib

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]